The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 21, 2014
Filed:
Aug. 23, 2013
Applicant:
Ligand Pharmaceuticals Incorporated, La Jolla, CA (US);
Inventors:
Lin Zhi, San Diego, CA (US);
Robert I. Higuchi, Solana Beach, CA (US);
Cornelis Arjan Van Oeveren, San Diego, CA (US);
Thomas Lot Stevens Lau, San Diego, CA (US);
Assignee:
Ligand Pharmaceuticals Incorporated, La Jolla, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 295/04 (2006.01); C07D 207/12 (2006.01); C07D 209/04 (2006.01); C07D 211/22 (2006.01); C07D 215/04 (2006.01); C07D 265/36 (2006.01); C07D 295/073 (2006.01); C07C 211/52 (2006.01); C07D 207/09 (2006.01); C07D 209/12 (2006.01); C07D 207/16 (2006.01); C07D 211/60 (2006.01); C07D 207/26 (2006.01); C07D 215/18 (2006.01); C07D 207/46 (2006.01); C07D 211/56 (2006.01); C07C 255/58 (2006.01); C07D 207/08 (2006.01); C07D 209/08 (2006.01);
U.S. Cl.
CPC ...
C07D 207/46 (2013.01); C07D 207/12 (2013.01); C07D 209/04 (2013.01); C07D 211/22 (2013.01); C07D 215/04 (2013.01); G01N 2333/723 (2013.01); C07D 265/36 (2013.01); C07D 295/073 (2013.01); C07C 211/52 (2013.01); C07D 207/09 (2013.01); C07D 209/12 (2013.01); C07D 207/16 (2013.01); C07D 211/60 (2013.01); C07D 207/26 (2013.01); C07D 215/18 (2013.01); C07D 211/56 (2013.01); C07C 255/58 (2013.01); C07D 207/08 (2013.01); C07D 209/08 (2013.01);
Abstract
Provided herein are compounds having a structure selected from among Formula (I), Formula (II), Formula (III), Formula (IV), Formula (V) and Formula (VI) that are androgen receptor modulators and/or androgen receptor binding agents. Also disclosed are methods of making and using such compounds, including, but not limited to, using such compounds for treating various conditions.